Association between YAP expression in neoplastic and non-neoplastic breast tissue with arsenic urinary levels
Name:
YAP PubMed version.pdf
Size:
88.81Kb
Format:
PDF
Description:
Final Accepted Manuscript
Author
Gladis, Michel-RamirezRecio-Vega, Rogelio
Ocampo-Gomez, Guadalupe
Palacios-Sanchez, Eduardo
Delgado-Macias, Manuel
Delgado-Gaona, Manuel
Clark Lantz, Robert
Gandolfi, Jay
Gonzalez-Cortes, Tania
Affiliation
University of Coahuila, Torreon, Coahuila, MexicoUniversity of Arizona, Tucson, AZ, USA
Univ Arizona, Southwest Environm Hlth Sci Ctr
Univ Arizona, Dept Cellular & Mol Med
Univ Arizona, Dept Pharmacol & Toxicol
Issue Date
2017-10-01
Metadata
Show full item recordPublisher
WILEYCitation
Michel‐Ramirez, G., Recio‐Vega, R., Ocampo‐Gomez, G., Palacios‐Sanchez, E., Delgado‐Macias, M., Delgado‐Gaona, M., ... & Gonzalez‐Cortes, T. (2017). Association between YAP expression in neoplastic and non‐neoplastic breast tissue with arsenic urinary levels. Journal of Applied Toxicology, 37(10), 1195-1202.Journal
Journal of Applied ToxicologyRights
Copyright © 2017 John Wiley & Sons, Ltd.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
The Hippo pathway regulates cell proliferation and apoptosis and it has been noted that loss of critical components of this pathway can lead to uncontrolled cell growth. Yes-associated protein (YAP) is an important component of this Hippo pathway because YAP is the nuclear effector of the Hippo tumor suppressor pathway and it is crucial for the response to oxidative stress induced by cellular process and by different xenobiotics, including arsenic. It has been proposed that YAP dysregulation can contribute to a malignant cellular phenotype acting as both a tumor suppressor and an oncogene. The aim of the study was to assess and compare the expression of YAP in neoplastic and non-neoplastic breast tissue of women chronically exposed to arsenic through drinking water. YAP expression was assessed by immunohistochemistry in 120 breast biopsies from women with breast cancer and from women with other non-neoplastic breast pathologies. Arsenic concentration was quantified in urine. The results disclosed a significant lower percentage of cytoplasm YAP expression in cases and that YAP high-intensity staining in the cytoplasm but not in the nucleus decreases the risk for breast cancer. In conclusion, our overall data suggest that YAP may act as a tumor suppressor protein because their reduced expression in cases, which can induce an environment favorable for inhibition of apoptosis and promoting cellular proliferation by increasing genetic instability of cells, which might contribute to the pathogenesis of cancer.Note
12 month embargo; first published: 19 May 2017ISSN
1099-1263PubMed ID
28524356PubMed Central ID
PMC5790116DOI
10.1002/jat.3481Version
Final accepted manuscriptSponsors
University of Coahuila; Superfund National Institute of Environmental Health Sciences [NIH ES-04940]ae974a485f413a2113503eed53cd6c53
10.1002/jat.3481